Tranzyme Stops Another Trial of Gastric Drug

Published December 19, 2012

Tranzyme stops another trial of gastric drug

Filed under: drug treatment news 2010

The drug, TZP-102, is still in early-stage trials for the treatment of other chronic gastrointestinal motility disorders. Tranzyme, which went public in April 2010 at $ 4 per share, has two other products in early testing. The company's experimental …
Read more on Reuters

Safeway Surpasses Goal in Cage-Free Egg Animal Welfare Effort

Filed under: drug treatment news 2010

In 2010, Safeway announced a goal of increasing sales of cage-free eggs from 6 percent to 12 percent of the shell egg category within two years. Today more than 15 percent of overall egg sales in the category are cage-free eggs. In addition, the …
Read more on Equities.com

As Diabetes Cases Increase in America, so Does Vision Loss

Filed under: drug treatment news 2010

And the FDA reports that 3.9 million adults with diabetes said they had trouble seeing in 2010. In August, the FDA approved a new drug to treat macular edema: Lucentis. The guidelines for administering the monthly injections require physicians to make …
Read more on DrugWatch.com